PostęPy w diagnostyce i leczeniu nabytych zastawkowych wad serca

Piśmiennictwo
1. Fedak PW, Dawid TE, Borger M, et al.: Bicuspid aortic valve disease: resent insights in pathophysiology
and treatment. Expert Rev, Cardiovasc Ther 2005, 3 (2): 295-308-
2. Fedak PW, Verma S, David TE, et al.: Clinical and pathophysiological implications of a bicuspid
aortic valve. Circulation 2002, 106: 900-904.
3. Huntington K, Humter AG, Chan KL. A prospective study to assess the frequency of familial clustering
of congenital bicuspid aortic vaalve. J Am Coll Cardiol. 1997; 30: 1809-1812.
4. Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis.
Circ Res. 1995; 77: 1-6.
5. Sabet HY, Edwards WD, Tazelaar HD, Daly RC. Congenitally bicuspid aortic valves: a surgical pathology
study of 542 cases (1991through 1996) and a literature review of 2715 additional cases. Mayo
Clin Proc. 1999; 74 (1): 14-26.
6. Angelini A, Ho SY, Anderson RH, Devine WA, Zuberbuhler JR, Becker AE, et al. The morphology
of the normal aortic valve as compared with the aortic valve having two leaflets. J Thorac Cardiovasc
Surg. 1989; 98: 362-7.
7. Schaefer BM, Lewin MB, Stout KK, Gill E, Prueitt A, Byers PH, Otto CM. The bicuspid aortic valve:
an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 2008 Dec;
94 (12): 1634-8.
8. Różański J, Barańska K, Kuśmierczyk M, et al.: Wrodzone zwężenie zastawki aortalnej u dorosłych,
Zeszyty edukacyjne, Kard Dyp 2006; 2: 31-33.
9. Ferencik M, Pape LA. Changes in size of ascending aorta and aortic valve function with time in
patients with congenitally bicuspid aortic valves. Am J Cardiol 2003; 92: 43-6.
10. Borger MA, David TE: Management of the valve and ascending aorta in adults with bicuspid aortic
valve disease. Semin Thorac Cardiovasc Surg 2005, 17: 143-147.
11. Guntheroth WG. A critical review of the American College of Cardiology/American Heart Association
practice guidelines on bicuspid aortic valve with dilated ascending aorta. Am J Cardiol. 2008
Jul 1; 102 (1): 107-1.
12. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung
B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular
heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society
of Cardiology. Eur Heart J 2007; 28:230-268.
13. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon, D.P. Faxon, M.D. Freed, W.H. Gaasch,
B.W. Lytle, R.A. Nishimura, P.T. O’Gara, R.A. O’Rourke, C.M. Otto, P.M. Shah, J.S. Shanewise,
S.C. Smith, A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, D.P. Faxon, V. Fuster, J.L. Halperin,
L.F. Hiratzka, S.A. Hunt, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel. ACC/AHA 2006 guidelines
for the management of patients with valvular heart disease. A Report of the American College
of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee
to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed
in collaboration with the Society of Cardiovascular Anesthesiologists, J Am Coll Cardiol, 2006;
48 (3): e1-e148.
14. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009),
Eur Heart J, 2009; 30, 2369-2413.
81